Barclays’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-13
| Closed | – | – | 4118 |
|
|
2019
Q4 | $0 | Sell |
13
-84
| -87% | – | ﹤0.01% | 4478 |
|
|
2019
Q3 | $0 | Sell |
97
-7,661
| -99% | – | ﹤0.01% | 4622 |
|
|
2019
Q2 | $51K | Buy |
7,758
+5,627
| +264% | +$37K | ﹤0.01% | 3826 |
|
|
2019
Q1 | $8K | Buy |
2,131
+1,831
| +610% | +$6.87K | ﹤0.01% | 4041 |
|
|
2018
Q4 | $1K | Sell |
300
-3,002
| -91% | -$10K | ﹤0.01% | 4057 |
|
|
2018
Q3 | $64K | Buy |
3,302
+2,086
| +172% | +$40.4K | ﹤0.01% | 3641 |
|
|
2018
Q2 | $39K | Sell |
1,216
-826
| -40% | -$26.5K | ﹤0.01% | 3388 |
|
|
2018
Q1 | $74K | Sell |
2,042
-4,260
| -68% | -$154K | ﹤0.01% | 3315 |
|
|
2017
Q4 | $498K | Buy |
+6,302
| New | +$498K | ﹤0.01% | 2097 |
|